Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$32.9 - $47.0 $9.59 Million - $13.7 Million
291,570 Added 402.76%
363,963 $12.1 Million
Q1 2024

May 13, 2024

BUY
$41.76 - $74.73 $1.05 Million - $1.88 Million
25,093 Added 53.05%
72,393 $3.47 Million
Q4 2023

Feb 14, 2024

SELL
$58.16 - $75.44 $16.3 Million - $21.2 Million
-281,085 Reduced 85.6%
47,300 $3.49 Million
Q3 2023

Nov 14, 2023

BUY
$70.9 - $88.63 $22.7 Million - $28.4 Million
320,271 Added 3947.14%
328,385 $24 Million
Q2 2023

Aug 14, 2023

BUY
$81.09 - $94.16 $657,964 - $764,014
8,114 New
8,114 $672,000
Q4 2022

Feb 14, 2023

SELL
$66.93 - $97.5 $54.6 Million - $79.5 Million
-815,274 Reduced 66.37%
413,033 $35.4 Million
Q3 2022

Nov 14, 2022

BUY
$69.86 - $107.63 $54.3 Million - $83.6 Million
777,187 Added 172.28%
1,228,307 $87.8 Million
Q2 2022

Aug 15, 2022

BUY
$89.06 - $117.64 $40.2 Million - $53.1 Million
451,120 New
451,120 $43.8 Million

Others Institutions Holding QDEL

About QuidelOrtho Corp


  • Ticker QDEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 66,952,900
  • Market Cap $2.91B
  • Description
  • QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...
More about QDEL
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.